세계의 수술 시뮬레이션 시장 : 모델 유형별, 기능별, 용도별, 최종사용자별, 지역별 예측(-2032년)

Global Surgical Simulation Market Research Report Information by Model Type (Reality {Synthetic Bench, Cadaveric, Animal, Full Immersion}, Virtual {Augmented Reality, Computer Aided, Others}), by Function (Medical Training, Medical Device Development), by Application (Laparoscopic Surgery, Cardiac Surgery, Gynecological Surgery, Neurological Surgery, Endoscopic Surgery, Others), by End User (Hospitals, Academic & Research Institutes, Surgical Centers, Military Organizations, Medical Device Companies) and by Region (North America, Europe, Asia-Pacific, and the Rest of the World)- Forecast to 2032

Market Synopsis

In 2023, the size of the global surgical simulation market was estimated to be USD 0.39 billion. According to projections, the global surgical simulation market is expected to increase at a compound annual growth rate (CAGR) of 14.42% from USD 0.45 billion in 2024 to USD 1.5 billion by 2032. The aging population, greater emphasis on patient safety, and technological improvements are the main drivers of the global market's expansion.

Numerous important elements are propelling the spectacular expansion of the surgical simulation market. The growing emphasis on patient safety is one of the main factors contributing to this growth. The World Health Organization (WHO) reports that up to 4 out of 10 patients globally experience injury during primary and outpatient care, and that up to 80% of these unfavorable outcomes can be prevented. One of the biggest concerns in the healthcare sector is patient safety. Surgical operations are inherently risky, and any mistake or issue could leave a patient's life permanently changed or even in danger.

Additionally, haptic feedback is frequently included in surgical simulators, allowing students to experience tactile sensations during simulated surgeries. By simulating touch and resistance that a surgeon would experience during a real surgery, this tactile feedback improves the learning process. It enables students to hone their delicate and accurate touch, an essential surgical ability. Beyond training, surgical simulation has a significant impact on patient safety. It's important for research and development as well. Before implementing novel surgical methods, tools, and processes in real-world settings, researchers can test and improve them in simulators. The market is growing as a result of these factors.

Insights on Market Segments

The surgical simulation market is divided into reality and virtual segments based on the type of model.

The market has been divided into two segments based on function: medical device development and medical training.

The surgical simulation market has been divided into segments according to application, including endoscopic, neurological, gynecological, cardiac, laparoscopic, and others.

Hospitals, surgical centers, academic & research institutes, military organizations, and medical device businesses make up the market's end user segments.

Regional Perspectives

The market is divided into four regions by the study: North America, Europe, Asia-Pacific, and the Rest of the World. Due in major part to early adoption of cutting-edge technologies and product innovation by market participants, North America held the greatest market share in 2022-more than 39.49%.

Because medical simulation is being used more often, the European surgical simulation industry is expected to rise significantly between 2024 and 2032. In Germany in 2020, 24.5% of men were obese and 43.8% were overweight, according to the Global Obesity Observatory 2021 report. Because of these percentages, the National Obesity Risk for Germany in 2021 was projected to be 7/10, which was significantly higher. Due to the heightened awareness of obesity brought about by this situation, most people in Germany are choosing minimally invasive aesthetic procedures as a means of losing weight.

Because healthcare spending in Asian nations is rising, the Asia-Pacific surgical simulation market is expected to develop at the quickest rate throughout the projected period. Moreover, all undergraduate programs are required to include simulation-based instruction by the Indian government. The expansion of the regional market would be aided by such government measures.

Principal Players

Surgical Science (Sweden), Mentice (Sweden), VirtaMed AG (Switzerland), 3-Dmed Learning Through Simulation (US), Laerdal Medical (Norway), Gaumard Scientific (US), Materialise (Belgium), Stratasys (Israel), and CAE Inc. (Canada) are some of the major players in the surgical simulation market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 Data Mining Process
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 Secondary Research data flow:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 Primary Research DATA FLOW:
  • 3.5.2 Primary Research: Number of Interviews conducted
  • 3.5.3 Primary Research: Regional Coverage
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 Revenue Analysis Approach
• 3.7 DATA FORECASTING
  • 3.7.1 Data forecasting Technique
• 3.8 DATA MODELING
  • 3.8.1 microeconomic factor analysis:
  • 3.8.2 Data modeling:

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 Increasing focus on patient safety
  • 4.2.2 growing geriatric population
  • 4.2.3 Advancements in Technology
• 4.3 RESTRAINTS
  • 4.3.1 Lack of StandardizatioN
• 4.4 OPPORTUNITY
  • 4.4.1 Regulatory Support for surgical simulation

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D
  • 5.1.2 Manufacturing
  • 5.1.3 Distribution And Sales
  • 5.1.4 Post-Sales Monitoring
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 Threat of New Entrants
  • 5.2.2 Bargaining Power of Suppliers
  • 5.2.3 Threat of Substitutes
  • 5.2.4 Bargaining Power of Buyers
  • 5.2.5 Intensity of Rivalry
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL SURGICAL SIMULATION MARKET
  • 5.3.1 impact on supply chain
  • 5.3.2 IMPACT ON KEY PLAYERS
  • 5.3.3 IMPACT ON DEMAND AND SUPPLY
• 5.4 LATEST APPROACHES IN SURGICAL SIMULATION TRAINING AND DEVICE DEVELOPMENT
• 5.5 QUALITATIVE ANALYSIS ON CADAVER USE IN SURGICAL SIMULATION
  • 5.5.1 Pricing Analysis
  • 5.5.2 Consumption Analysis
• 5.6 LIST OF KEY PROVIDERS OF CADAVERS

6 GLOBAL SURGICAL SIMULATION MARKET, BY MODEL TYPE

• 6.1 OVERVIEW
• 6.2 REALITY
  • 6.2.1 Synthetic Bench
  • 6.2.2 Cadaveric
  • 6.2.3 Animal
  • 6.2.4 Full Immersion
• 6.3 VIRTUAL
  • 6.3.1 Augmented Reality
  • 6.3.2 Computer Aided
  • 6.3.3 Others

7 GLOBAL SURGICAL SIMULATION MARKET, BY FUNCTION

• 7.1 OVERVIEW
• 7.2 MEDICAL TRAINING
• 7.3 MEDICAL DEVICE DEVELOPMENT

8 GLOBAL SURGICAL SIMULATION MARKET, BY APPLICATION

• 8.1 OVERVIEW
• 8.2 LAPAROSCOPIC SURGERY
• 8.3 CARDIAC SURGERY
• 8.4 GYNAECOLOGICAL SURGERY
• 8.5 NEUROLOGICAL SURGERY
• 8.6 ENDOSCOPIC SURGERY
• 8.7 OTHERS

9 GLOBAL SURGICAL SIMULATION MARKET, BY END USER

• 9.1 OVERVIEW
• 9.2 HOSPITALS
• 9.3 ACADEMIC & RESEARCH INSTITUTES
• 9.4 SURGICAL CENTERS
• 9.5 MILITARY ORGANIZATIONS
• 9.6 MEDICAL DEVICE COMPANIES

10 GLOBAL SURGICAL SIMULATION MARKET, BY REGION

• 10.1 OVERVIEW
• 10.2 NORTH AMERICA
  • 10.2.1 US
  • 10.2.2 CANADA
• 10.3 EUROPE
  • 10.3.1 Germany
  • 10.3.2 France
  • 10.3.3 UK
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Rest of Europe
• 10.4 ASIA-PACIFIC
  • 10.4.1 China
  • 10.4.2 India
  • 10.4.3 Japan
  • 10.4.4 South Korea
  • 10.4.5 Australia
  • 10.4.6 Rest of Asia-Pacific
• 10.5 REST OF THE WORLD
  • 10.5.1 Middle East
  • 10.5.2 Africa
  • 10.5.3 Latin America

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 MARKET SHARE ANALYSIS,
• 11.3 COMPETITOR DASHBOARD
• 11.4 PUBLIC PLAYERS STOCK SUMMARY
• 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
• 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 11.6.1 Product Launch
  • 11.6.2 Partnership/acquisition
  • 11.6.3 Expansion

12 COMPANY PROFILES

• 12.1 SURGICAL SCIENCE
  • 12.1.1 COMPANY OVERVIEW
  • 12.1.2 FINANCIAL OVERVIEW
  • 12.1.3 Products OFFERed
  • 12.1.4 KEY DEVELOPMENTS
  • 12.1.5 SWOT ANALYSIS
  • 12.1.6 Key Strategy
• 12.2 MENTICE
  • 12.2.1 COMPANY OVERVIEW
  • 12.2.2 FINANCIAL OVERVIEW
  • 12.2.3 Products OFFERed
  • 12.2.4 KEY DEVELOPMENTS
  • 12.2.5 Key Strategy
• 12.3 SIMULAB CORPORATION
  • 12.3.1 COMPANY OVERVIEW
  • 12.3.2 FINANCIAL OVERVIEW
  • 12.3.3 PRODUCTS OFFERED
  • 12.3.4 Key developments
  • 12.3.5 KEY STRATEGIES
• 12.4 VIRTAMED AG
  • 12.4.1 COMPANY OVERVIEW
  • 12.4.2 FINANCIAL OVERVIEW
  • 12.4.3 PRODUCTS OFFERED
  • 12.4.4 KEY DEVELOPMENTS
  • 12.4.5 SWOT ANALYSIS
  • 12.4.6 KEY STRATEGIES
• 12.5 3-DMED LEARNING THROUGH SIMULATION
  • 12.5.1 COMPANY OVERVIEW
  • 12.5.2 FINANCIAL OVERVIEW
  • 12.5.3 PRODUCTS OFFERED
  • 12.5.4 KEY DEVELOPMENTS
  • 12.5.5 KEY STRATEGIES
• 12.6 LAERDAL MEDICAL
  • 12.6.1 COMPANY OVERVIEW
  • 12.6.2 FINANCIAL OVERVIEW
  • 12.6.3 PRODUCTS OFFERED
  • 12.6.4 KEY DEVELOPMENTS
  • 12.6.5 KEY STRATEGIES
• 12.7 GAUMARD SCIENTIFIC
  • 12.7.1 COMPANY OVERVIEW
  • 12.7.2 FINANCIAL OVERVIEW
  • 12.7.3 PRODUCTS OFFERED
  • 12.7.4 KEY DEVELOPMENTS
  • 12.7.5 SWOT ANALYSIS
  • 12.7.6 KEY STRATEGIES
• 12.8 MATERIALISE
  • 12.8.1 COMPANY OVERVIEW
  • 12.8.2 FINANCIAL OVERVIEW
  • 12.8.3 PRODUCTS OFFERED
  • 12.8.4 KEY DEVELOPMENTS
  • 12.8.5 SWOT ANALYSIS
  • 12.8.6 KEY STRATEGIES
• 12.9 STRATASYS
  • 12.9.1 COMPANY OVERVIEW
  • 12.9.2 FINANCIAL OVERVIEW
  • 12.9.3 PRODUCTS OFFERED
  • 12.9.4 KEY DEVELOPMENTS
  • 12.9.5 KEY STRATEGIES
• 12.10 CAE INC
  • 12.10.1 COMPANY OVERVIEW
  • 12.10.2 FINANCIAL OVERVIEW
  • 12.10.3 PRODUCTS OFFERED
  • 12.10.4 KEY DEVELOPMENTS
  • 12.10.5 SWOT ANALYSIS
  • 12.10.6 KEY STRATEGIES